The potential of novel ribonucleotide reductase inhibitors, Didox and Trimidox, compared to hydroxyurea to enhance NRTI antiviral activity in vivo

被引：0
|
作者：
Sumpter, R
Elford, H
Inayat, M
Sugg, T
Tsai, P
Gallicchio, V
机构：
[1] Mol Hlth Inc, Richmond, VA USA
[2] Univ Kentucky, Lexington, KY USA
来源：
ANTIVIRAL RESEARCH | 2003年 / 57卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
26
引用
收藏
页码：A48 / A48
页数：1
相关论文
共 45 条
  • [21] Anti-retroviral activity of ribonucleotide reductase inhibitors Didox and Trimidox in a murine acquired immunodeficiency (MAIDS) model either alone or in combination with DDI.
    Gallicchio, VS
    Mayhew, C
    Oakley, OR
    Hughes, NK
    Piper, J
    Elford, HL
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 378 - 378
  • [22] Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase with improved in vivo antiviral activity
    Moss, N
    Beaulieu, P
    Duceppe, JS
    Ferland, JM
    Garneau, M
    Gauthier, J
    Ghiro, E
    Goulet, S
    Guse, I
    Jaramillo, J
    LlinasBrunet, M
    Malenfant, E
    Plante, R
    Poirier, M
    Soucy, F
    Wernic, D
    Yoakim, C
    Deziel, R
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (21) : 4173 - 4180
  • [23] Inhibition of lymphoproliferation and late-stage lymphoma in LP-BM5 murine leukemia virus (MuLV) infection by ribonucleotide reductase inhibitors trimidox and didox alone, compared with hydroxyurea, and in combination with 2′, 3′-dideoxyinosine (ddI).
    Gallicchio, VS
    Mayhew, CN
    Elford, HL
    BLOOD, 2000, 96 (11) : 342A - 342A
  • [24] Activity of the Novel Ribonucleotide Reductase Inhibitor Didox on Human and Murine Models of Acute Leukemia
    Cook, Guerry J.
    Elford, Howard L.
    Pardee, Timothy
    BLOOD, 2011, 118 (21) : 1553 - 1554
  • [25] Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice
    Novotny, L
    Rauko, P
    Liska, J
    Elford, HL
    Szekeres, T
    CANCER LETTERS, 2006, 233 (01) : 178 - 184
  • [26] Effective use of ribonucleotide reductase inhibitors (Didox and Trimidox) alone or in combination with didanosine (ddI) to suppress disease progression and increase survival in murine acquired immunodeficiency syndrome (MAIDS)
    Mayhew, C
    Oakley, O
    Piper, J
    Hughes, NK
    Phillips, J
    Birch, NJ
    Elford, HL
    Gallicchio, VS
    CELLULAR AND MOLECULAR BIOLOGY, 1997, 43 (07) : 1019 - 1029
  • [27] A POTENT PEPTIDOMIMETIC INHIBITOR OF HSV RIBONUCLEOTIDE REDUCTASE WITH ANTIVIRAL ACTIVITY IN-VIVO
    LIUZZI, M
    DEZIEL, R
    MOSS, N
    BEAULIEU, P
    BONNEAU, AM
    BOUSQUET, C
    CHAFOULEAS, JG
    GARNEAU, M
    JARAMILLO, J
    KROGSRUD, RL
    LAGACE, L
    MCCOLLUM, RS
    NAWOOT, S
    GUINDON, Y
    NATURE, 1994, 372 (6507) : 695 - 698
  • [28] Enhancement of hemoglobin and F-cell production by targeting growth inhibition and differentiation of K562 cells with ribonucleotide reductase inhibitors (didox and trimidox) in combination with streptozotocin
    Iyamu, WE
    Adunyah, SE
    Fasold, H
    Horiuchi, K
    Elford, HL
    Asakura, T
    Turner, EA
    AMERICAN JOURNAL OF HEMATOLOGY, 2000, 63 (04) : 176 - 183
  • [29] IMPLICATIONS AND PROBLEMS IN ANALYZING CYTOTOXIC ACTIVITY OF HYDROXYUREA IN COMBINATION WITH A POTENTIAL INHIBITOR OF RIBONUCLEOTIDE REDUCTASE
    NOCENTINI, G
    BARZI, A
    FRANCHETTI, P
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (05) : 345 - 351
  • [30] Design and synthesis of potential ribonucleotide reductase enzyme (RNR) inhibitors as antileukemic and/or antiviral 2 '-deoxymethylene nucleosides
    Youssef, Khairia M.
    Lien, Eric J.
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 1 (02) : 42 - 49
12345